Metabolic dysfunction, particularly within mitochondria, serves as a primary driver for various psychiatric and neurological disorders, including schizophrenia, bipolar disorder, and treatment-resistant depression. By shifting brain metabolism away from glucose dependency toward ketone utilization, therapeutic diets like the ketogenic protocol stimulate mitophagy and mitochondrial biogenesis, effectively repairing cellular energy regulation. Dr. Chris Palmer, a Harvard psychiatrist, demonstrates this through clinical case studies, such as a patient with schizoaffective disorder who achieved full remission of auditory hallucinations and paranoia after adopting a ketogenic lifestyle. These nutritional interventions function similarly to established epilepsy treatments, which also target metabolic pathways to stabilize neurotransmitter levels and reduce neuroinflammation. Addressing the underlying metabolic derangement offers a potent, non-pharmacological lever for stabilizing mood, cognition, and overall mental health, potentially transforming the standard of care for chronic psychiatric conditions.
Sign in to continue reading, translating and more.
Continue
